Ester Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 8:38 pm

Competitors of Ester Industries Ltd

All Competitor Stocks of Ester Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:40 pm

Below is a detailed analysis of the quarterly data for Ester Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 338.20 Cr.. The value appears strong and on an upward trend. It has increased from 319.26 Cr. (Mar 2025) to 338.20 Cr., marking an increase of 18.94 Cr..
• For Expenses, as of Jun 2025, the value is 317.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 282.80 Cr. (Mar 2025) to 317.89 Cr., marking an increase of 35.09 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.31 Cr.. The value appears to be declining and may need further review. It has decreased from 36.46 Cr. (Mar 2025) to 20.31 Cr., marking a decrease of 16.15 Cr..
• For OPM %, as of Jun 2025, the value is 6.01%. The value appears to be declining and may need further review. It has decreased from 11.42% (Mar 2025) to 6.01%, marking a decrease of 5.41%.
• For Other Income, as of Jun 2025, the value is 8.65 Cr.. The value appears strong and on an upward trend. It has increased from 2.66 Cr. (Mar 2025) to 8.65 Cr., marking an increase of 5.99 Cr..
• For Interest, as of Jun 2025, the value is 15.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.66 Cr. (Mar 2025) to 15.48 Cr., marking a decrease of 0.18 Cr..
• For Depreciation, as of Jun 2025, the value is 17.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.09 Cr. (Mar 2025) to 17.29 Cr., marking an increase of 0.20 Cr..
• For Profit before tax, as of Jun 2025, the value is -3.81 Cr.. The value appears to be declining and may need further review. It has decreased from 6.37 Cr. (Mar 2025) to -3.81 Cr., marking a decrease of 10.18 Cr..
• For Tax %, as of Jun 2025, the value is 87.66%. The value appears to be increasing, which may not be favorable. It has increased from 69.23% (Mar 2025) to 87.66%, marking an increase of 18.43%.
• For Net Profit, as of Jun 2025, the value is -7.16 Cr.. The value appears to be declining and may need further review. It has decreased from 1.96 Cr. (Mar 2025) to -7.16 Cr., marking a decrease of 9.12 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.73. The value appears to be declining and may need further review. It has decreased from 0.21 (Mar 2025) to -0.73, marking a decrease of 0.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:23 am

Growth

Last Updated: September 5, 2025, 3:45 am

Balance Sheet

Last Updated: June 16, 2025, 12:11 pm

Below is a detailed analysis of the balance sheet data for Ester Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 47.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 47.00 Cr..
• For Reserves, as of Mar 2025, the value is 726.00 Cr.. The value appears strong and on an upward trend. It has increased from 671.00 Cr. (Mar 2024) to 726.00 Cr., marking an increase of 55.00 Cr..
• For Borrowings, as of Mar 2025, the value is 660.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 773.00 Cr. (Mar 2024) to 660.00 Cr., marking a decrease of 113.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 140.00 Cr.. The value appears to be improving (decreasing). It has decreased from 153.00 Cr. (Mar 2024) to 140.00 Cr., marking a decrease of 13.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,573.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,643.00 Cr. (Mar 2024) to 1,573.00 Cr., marking a decrease of 70.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 977.00 Cr.. The value appears to be declining and may need further review. It has decreased from 989.00 Cr. (Mar 2024) to 977.00 Cr., marking a decrease of 12.00 Cr..
• For CWIP, as of Mar 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2024) to 39.00 Cr., marking a decrease of 44.00 Cr..
• For Investments, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Mar 2024) to 75.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 482.00 Cr.. The value appears to be declining and may need further review. It has decreased from 502.00 Cr. (Mar 2024) to 482.00 Cr., marking a decrease of 20.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,573.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,643.00 Cr. (Mar 2024) to 1,573.00 Cr., marking a decrease of 70.00 Cr..

Notably, the Reserves (726.00 Cr.) exceed the Borrowings (660.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ester Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 5. It has increased from -14.49 (Mar 24) to 1.46, marking an increase of 15.95.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 5. It has increased from -14.49 (Mar 24) to 1.46, marking an increase of 15.95.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.79. This value is within the healthy range. It has increased from -5.64 (Mar 24) to 8.79, marking an increase of 14.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.15. It has increased from 76.37 (Mar 24) to 82.15, marking an increase of 5.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 82.15. It has increased from 76.37 (Mar 24) to 82.15, marking an increase of 5.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 136.34. It has increased from 113.19 (Mar 24) to 136.34, marking an increase of 23.15.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.45. This value is within the healthy range. It has increased from 0.36 (Mar 24) to 17.45, marking an increase of 17.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 10.14. This value is within the healthy range. It has increased from -6.88 (Mar 24) to 10.14, marking an increase of 17.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.98. This value is within the healthy range. It has increased from -14.37 (Mar 24) to 2.98, marking an increase of 17.35.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 2. It has increased from -12.88 (Mar 24) to 1.48, marking an increase of 14.36.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 2. It has increased from -12.88 (Mar 24) to 1.46, marking an increase of 14.34.
• For PBDIT Margin (%), as of Mar 25, the value is 12.79. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 12.79, marking an increase of 12.48.
• For PBIT Margin (%), as of Mar 25, the value is 7.43. This value is below the healthy minimum of 10. It has increased from -6.07 (Mar 24) to 7.43, marking an increase of 13.50.
• For PBT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has increased from -12.69 (Mar 24) to 2.18, marking an increase of 14.87.
• For Net Profit Margin (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 5. It has increased from -11.38 (Mar 24) to 1.08, marking an increase of 12.46.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 8. It has increased from -11.38 (Mar 24) to 1.06, marking an increase of 12.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 15. It has increased from -16.86 (Mar 24) to 1.77, marking an increase of 18.63.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.68. This value is below the healthy minimum of 10. It has increased from -5.32 (Mar 24) to 7.68, marking an increase of 13.00.
• For Return On Assets (%), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 5. It has increased from -7.36 (Mar 24) to 0.87, marking an increase of 8.23.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.52. This value is within the healthy range. It has decreased from 0.61 (Mar 24) to 0.52, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.85. This value is within the healthy range. It has decreased from 1.08 (Mar 24) to 0.85, marking a decrease of 0.23.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has increased from 0.63 (Mar 24) to 0.79, marking an increase of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 1.52. This value is within the healthy range. It has increased from 1.27 (Mar 24) to 1.52, marking an increase of 0.25.
• For Quick Ratio (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.04, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.18. This value is within the healthy range. It has increased from 4.80 (Mar 24) to 5.18, marking an increase of 0.38.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -3.44 (Mar 24) to 0.00, marking an increase of 3.44.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -7.86 (Mar 24) to 0.00, marking an increase of 7.86.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 103.44 (Mar 24) to 0.00, marking a decrease of 103.44.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 107.86 (Mar 24) to 0.00, marking a decrease of 107.86.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.44. This value is below the healthy minimum of 3. It has increased from 0.04 (Mar 24) to 2.44, marking an increase of 2.40.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has increased from -0.72 (Mar 24) to 1.21, marking an increase of 1.93.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,725.34. It has increased from 1,457.07 (Mar 24) to 1,725.34, marking an increase of 268.27.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.35, marking a decrease of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 430.02 (Mar 24) to 10.51, marking a decrease of 419.51.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.88, marking an increase of 0.13.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 103.44 (Mar 24) to 0.00, marking a decrease of 103.44.
• For Price / BV (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has increased from 1.12 (Mar 24) to 1.47, marking an increase of 0.35.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.88, marking an increase of 0.13.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.15 (Mar 24) to 0.01, marking an increase of 0.16.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness